This site is intended for Healthcare professionals only.

Lupin receives tentative approval from USFDA for Generic Rapaflo Capsules

Lupin receives tentative approval from USFDA for Generic Rapaflo Capsules

Pharma Major Lupin Limited (Lupin) announced that it has received tentative approval for its Silodosin Capsules, 4 mg and 8 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Allergan Sales, LLC’s Rapaflo Capsules, 4 mg and 8 mg.

Lupin’s Silodosin Capsules, 4 mg and 8 mg are the AB rated generic equivalent of Allergan Sales, LLC’s Rapaflo Capsules, 4 mg and 8 mg. It is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia.

Source: Press Release
1 comment(s) on Lupin receives tentative approval from USFDA for Generic Rapaflo Capsules

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted
  1. How Soon Do We See This Generic Rapaflo ??
    Thanks